Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	9.38	23.97	5.26	13.07	10.02	18.7
Cash & Short-Term Investments	9.38	23.97	5.26	13.07	10.02	18.7
Cash Growth	34.53%	356.19%	-59.79%	30.45%	-46.44%	257.42%
Accounts Receivable	12.02	13.17	23.87	21.97	13.39	18.4
Other Receivables	0.05	0.14	0.16	0.41	1.02	0.43
Receivables	12.08	13.31	24.03	22.38	14.41	18.83
Inventory	34.23	39.82	36.72	22.85	21.35	14.67
Prepaid Expenses	6.74	3.1	4.19	12.38	2.06	4.71
Other Current Assets	-	0.38	2.3	2.3	1.28	1.67
Total Current Assets	62.43	80.57	72.5	72.97	49.11	58.57
Property, Plant & Equipment	0.51	0.69	0.78	0.9	1.22	0.8
Goodwill	10.15	10	10.28	10.28	10.69	10.65
Other Intangible Assets	67.06	71.6	64.14	70.37	76.57	76.36
Long-Term Deferred Tax Assets	9.3	8.98	8.04	6.81	-	-
Other Long-Term Assets	-	-	-	-	1.64	2.13
Total Assets	149.44	171.84	155.73	161.33	139.23	148.51
Accounts Payable	37.69	5.73	7.75	10.16	12.05	14.86
Accrued Expenses	-	35.29	35.48	23.26	17.13	12.47
Current Portion of Long-Term Debt	20.83	36.79	15.74	42.71	15.05	10.57
Current Portion of Leases	0.12	0.19	-	-	-	-
Current Income Taxes Payable	1.75	1.37	1.32	1.18	0.03	0.51
Other Current Liabilities	14.55	17.94	5.94	6.19	3.86	1.53
Total Current Liabilities	74.94	97.31	66.23	83.5	48.11	39.94
Long-Term Debt	-0.1	-	33.61	26.78	39.03	34.09
Long-Term Leases	0.22	0.2	0.54	0.6	0.78	0.21
Long-Term Deferred Tax Liabilities	-	-	-	-	1.52	2.65
Other Long-Term Liabilities	21.96	22.19	25.03	28.01	31.99	53.61
Total Liabilities	97.02	119.7	125.41	138.88	121.43	130.5
Common Stock	96.44	96.1	76.39	69.01	68.69	66.69
Additional Paid-In Capital	11.71	12.01	12.01	11.31	10.38	9.5
Retained Earnings	-61.79	-62	-64.24	-64.03	-65.25	-62.37
Comprehensive Income & Other	6.06	6.03	6.17	6.16	3.97	4.2
Shareholders' Equity	52.42	52.14	30.32	22.45	17.79	18.02
Total Liabilities & Equity	149.44	171.84	155.73	161.33	139.23	148.51
Total Debt	21.07	37.18	49.9	70.08	54.86	44.87
Net Cash (Debt)	-11.69	-13.21	-44.64	-57.01	-44.84	-26.17
Net Cash Per Share	-0.38	-0.50	-2.00	-2.78	-2.26	-1.72
Filing Date Shares Outstanding	32.42	32.26	24.46	20.25	19.95	19.17
Total Common Shares Outstanding	32.42	32.26	24.46	20.18	19.95	19.17
Working Capital	-12.51	-16.74	6.27	-10.53	1	18.63
Book Value Per Share	1.62	1.62	1.24	1.11	0.89	0.94
Tangible Book Value	-24.79	-29.46	-44.09	-58.21	-69.46	-69
Tangible Book Value Per Share	-0.76	-0.91	-1.80	-2.88	-3.48	-3.60
Machinery	-	1.26	1.12	1.07	1.06	0.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.